Buprenorphine Hydrochloride Injection 0.3mg/mL
Endo USA recalls Buprenorphine Hydrochloride Injection 0.3mg/mL vials (NDC 42023-179-05) due to particulate matter contamination.
Do not use this medication. Contact your pharmacy or healthcare provider immediately if you have received this product. Return the vials to your pharmacy for proper disposal and obtain a replacement from an unaffected lot.
Why it was recalled
Presence of particulate matter: identified as Buprenorphine free base
How to identify it
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Where it was sold
Distributed in US.
Official source
Editorial summary by Recall Canary · last updated 2026-05-12 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification